首页|番泻苷A对胆囊癌细胞恶性生物学行为的影响及相关机制

番泻苷A对胆囊癌细胞恶性生物学行为的影响及相关机制

The effect of Sennoside A on malignant biological behavior of gallbladder cancer cells and the related mechanism

扫码查看
目的 探讨番泻苷A(SA)对胆囊癌细胞增殖、迁移、侵袭和糖酵解等恶性生物学行为的影响,并对其相关机制进行分析.方法 体外培养人胆囊癌NOZ和SGC-996细胞,并分别将其分为空白对照组、SA低剂量组(25 µmol/L)、SA中剂量组(50 μmol/L)、SA高剂量组(100 μmol/L)、H-SA+磷脂酰肌醇3激酶/蛋白激酶B(PI3K/AKT)信号通路激活剂(740Y-P)组.利用细胞计数实验、Transwell、流式细胞术和糖酵解试剂盒检测各组细胞的增殖、迁移、侵袭、凋亡和糖酵解能力;蛋白免疫印迹实验检测各组细胞中PI3K、AKT、p-PI3K、p-AKT的蛋白水平.使用NOZ细胞构建裸鼠成瘤模型,分别用生理盐水和10 mg/kg SA腹腔注射,比较两组小鼠的成瘤能力,免疫组化检测肿瘤中Ki-67的表达水平.结果 与空白对照组细胞相比,各SA处理组细胞的增殖、迁移、侵袭和糖酵解能力降低,而凋亡水平显著上调,差异均有统计学意义(均P<0.05).SA处理胆囊癌细胞使p-PI3K和p-AKT水平明显降低;而740Y-P激活PI3K/AKT通路后细胞的增殖、迁移、侵袭和糖酵解能力上调,凋亡水平降低,差异均有统计学意义(均P<0.05).体内成瘤实验标明,第28天时与空白对照组相比,SA 处理组小鼠的肿瘤体积降低[(1051.32±130.29)mm3 比(575.07±170.54)mm3,P=0.0 003],肿瘤重量减轻[(1.04±0.24)g 比(0.58±0.13)g,P=0.0019],Ki-67 表达平均光密度值降低[(77.00±7.00)比(33.33±7.51),P=0.0018].结论 SA通过调控PI3K/AKT通路抑制胆囊癌细胞的增殖、迁移、侵袭和糖酵解等恶性生物学行为.
Objective To investigate the effects of Sennoside A(SA)on the proliferation,migra-tion,invasion,glycolysis and other malignant biological behaviors of gallbladder carcinoma cells,and to analyze the related mechanisms.Methods Human gallbladder carcinoma cell lines,NOZ and SGC-996,were cultured in vitro and divided into control group,SA low dose group(L-SA,25 µmol/L),SA medium dose group(M-SA,50 μmol/L)and SA high dose group(H-SA,100 µmol/L),and H-SA+phosphati-dylinositol 3-kinase/protein kinase B(PI3K/AKT)signaling pathway activator 740Y-P group,respectively.The proliferation,migration,invasion,apoptosis and glycolysis of gallbladder cancer cells in each group were detected by cell counting assay,Transwell,flow cytometry and glycolysis kit.The protein levels of PI3K,p-PI3K,AKT and p-AKT were detected by Western blot assay.NOZ cells were used to construct tumor model of nude mice,and the mice were divided into saline treatment group and 10 mg/kg SA treat-ment group.The tumor formation ability of the two groups of mice was compared,and the expression level of Ki-67 in tumor of the two groups was detected by immunohistochemical assay.Results Compared with con-trol group,the proliferation,migration,invasion,glycolysis ability,the expression levels of p-PI3K and p-AKT were significantly decreased in SA treatment groups,while the apoptosis level was significantly up-regulated,all differences were statistically significant(P<0.05).Compared with H-SA group,the prolifer-ation,migration,invasion and glycolysis of H-SA+740Y-P group cells were up-regulated,while the apopto-sis level was significantly decreased,all differences were statistically significant(P<0.05).In vivo tumori-genesis experiments showed that,compared with the control group,the tumor volume of the SA-treated mice was reduced at day 28[(1 051.32±130.29)mm3 vs(575.07±170.54)mm3,P=0.0003),the tumor weight was reduced[(1.04±0.24)g vs(0.58±0.13)g,P=0.0019],and the average optical density of Ki-67 expression was reduced[(77.00±7.00)vs(33.33±7.51),P=0.0018].Conclusion SA can inhibit the proliferation,migration,invasion and glycolysis of gallbladder carcinoma cells by regulating PI3K/AKT pathway.

Gallbladder neoplasmsSennoside APhosphatidylinositol 3-kinase/kinase B path-wayGlycolysis

李姗姗、贾红玉、闫丽丽、徐梅梅

展开 >

秦皇岛市第一医院消化内科,秦皇岛 066000

胆囊肿瘤 番泻苷A 磷脂酰肌醇3激酶/蛋白激酶B信号通路 糖酵解

2024

中华肝胆外科杂志
中华医学会

中华肝胆外科杂志

CSTPCD北大核心
影响因子:1.846
ISSN:1007-8118
年,卷(期):2024.30(7)
  • 2